Evidence map›Paper›PMID 30717247›Full record

ArticleMicroorganisms2019

Optimization of In Vitro

Lauren Auster, Morgan Sutton, Mary Chandler Gwin, Christopher Nitkin, Tracey L Bonfield

Open access · goldAbstract read
In one paragraph

Article in Microorganisms, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Biofilm aggregates and the host airway-microbial interface.Frontiers in cellular and infection microbiology · 2022
    Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Lauren AusterDivision of Pulmonology, Allergy and Immunology, Department of Pediatrics, Case Western Reserve University School of Medicine, 10900 Euclid Ave. BRB 822, Cleveland, OH 44106, USA. Lauren.Auster@case.edu.
Morgan SuttonDivision of Pulmonology, Allergy and Immunology, Department of Pediatrics, Case Western Reserve University School of Medicine, 10900 Euclid Ave. BRB 822, Cleveland, OH 44106, USA. mxs1175@case.edu.
Mary Chandler GwinDivision of Pulmonology, Allergy and Immunology, Department of Pediatrics, Case Western Reserve University School of Medicine, 10900 Euclid Ave. BRB 822, Cleveland, OH 44106, USA. mary.gwin@yale.edu.ORCID 0000-0003-4579-2331
Christopher NitkinDivision of Pulmonology, Allergy and Immunology, Department of Pediatrics, Case Western Reserve University School of Medicine, 10900 Euclid Ave. BRB 822, Cleveland, OH 44106, USA. crnitkin@chm.edu.
Tracey L BonfieldDivision of Pulmonology, Allergy and Immunology, Department of Pediatrics, Case Western Reserve University School of Medicine, 10900 Euclid Ave. BRB 822, Cleveland, OH 44106, USA. Tracey.Bonfield@case.edu.ORCID 0000-0001-9698-9113
Case Western Reserve University · USChildren's Mercy Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infection with nontuberculous mycobacteria (NTM) is a complication of lung disease in immunocompromised patients, including those with human immunodeficiency virus and acquired immune deficiency syndrome (HIV/AIDS), chronic obstructive pulmonary disease (COPD), and cystic fibrosis (CF). The most widespread, disease-causing NTM is

Indexed as

anti-non-tuberculous mycobacterium therapeutic testingMycobacterium aviumMycobacterium intracellulareoptimized growth

Identifiers

PMID30717247
PMCPMC6406338
OpenAlexW2912423803

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.